PA
TMO icon

Procyon Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Procyon Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.9M Sell
5,787
-383
-6% -$184K 0.13% 154
2026
Q1 		$3.03M Sell
6,170
-208
-3% -$113K 0.15% 138
2025
Q4 		$3.7M Buy
6,378
+38
+0.6% +$21.5K 0.18% 116
2025
Q3 		$3.07M Sell
6,340
-989
-13% -$460K 0.18% 103
2025
Q2 		$2.97M Sell
7,329
-5,828
-44% -$2.44M 0.28% 74
2025
Q1 		$6.55M Buy
13,157
+1,556
+13% +$843K 0.4% 59
2024
Q4 		$6.03M Sell
11,601
-796
-6% -$438K 0.38% 56
2024
Q3 		$7.67M Sell
12,397
-248
-2% -$147K 0.52% 43
2024
Q2 		$6.99M Buy
12,645
+499
+4% +$286K 0.52% 47
2024
Q1 		$7.06M Buy
12,146
+2,196
+22% +$1.23M 0.55% 44
2023
Q4 		$5.28M Sell
9,950
-673
-6% -$326K 0.45% 49
2023
Q3 		$5.38M Buy
10,623
+2,987
+39% +$1.59M 0.55% 40
2023
Q2 		$3.98M Buy
7,636
+1,314
+21% +$709K 0.5% 47
2023
Q1 		$3.64M Sell
6,322
-1,291
-17% -$728K 0.61% 36
2022
Q4 		$4.19M Buy
7,613
+3,030
+66% +$1.61M 0.77% 34
2022
Q3 		$2.33M Buy
4,583
+299
+7% +$167K 0.57% 40
2022
Q2 		$2.33M Buy
4,284
+805
+23% +$443K 0.51% 44
2022
Q1 		$2.06M Buy
3,479
+1,389
+66% +$798K 0.42% 53
2021
Q4 		$1.4M Buy
2,090
+98
+5% +$61.2K 0.3% 81
2021
Q3 		$1.14M Buy
1,992
+185
+10% +$102K 0.29% 80
2021
Q2 		$912K Buy
1,807
+318
+21% +$150K 0.25% 89
2021
Q1 		$680K Buy
1,489
+45
+3% +$21.5K 0.3% 82
2020
Q4 		$673K Sell
1,444
-23
-2% -$10.8K 0.33% 81
2020
Q3 		$648K Buy
1,467
+90
+7% +$37.2K 0.36% 78
2020
Q2 		$499K Buy
1,377
+160
+13% +$53.6K 0.27% 82
2020
Q1 		$345K Buy
1,217
+144
+13% +$45.4K 0.23% 90
2019
Q4 		$349K Buy
+1,073
New +$325K 0.21% 103

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Procyon Advisors's TMO Position: Q2 2026 in Review

Procyon Advisors reduced its Thermo Fisher Scientific (TMO) stake by 6.2% in Q2 2026, selling an estimated $184K and leaving 5,787 shares worth $2.9M. The position accounts for 0.13% of the portfolio, ranked #154.

Procyon Advisors first reported a position in TMO in Q4 2019 and has held it in 27 quarters since. The position peaked at $7.67M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Procyon Advisors held 5,787 shares of Thermo Fisher Scientific worth $2.9M as of Q2 2026.
  • Procyon Advisors sold 383 Thermo Fisher Scientific shares in Q2 2026, an estimated $184K.
  • Thermo Fisher Scientific made up 0.13% of Procyon Advisors's portfolio in Q2 2026, its #154 holding.
  • Procyon Advisors first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 27 quarters since.
  • Procyon Advisors's Thermo Fisher Scientific position peaked at $7.67M in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Procyon Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.